Michael L. Cunningham
Michael Cunningham received a B.A. degree in biochemistry and molecular biology, a B.A. degree in pharmacology from the University of California at Santa Barbara, and a Ph.D. degree in pharmacology and toxicology from the University of Arizona in Tucson, USA. He then served as a Postdoctoral Fellow at Sandoz Research Institute and Argonne National Laboratory before coming to the National Institutes of Health (NIH) at the National Institute of Environmental Health Sciences (NIEHS) in the Research Triangle Park (NC, USA) in 1987. He is presently a Toxicologist in the National Toxicology Program (NTP). His research interests concern the mechanisms of toxicity and carcinogenicity of NTP chemicals. His current research approaches involve the use of transgenic in vivo mutagenicity models for the assessment of genetic toxicity and genomic technologies for the assessment of acute and subchronic toxicity. He is certified in general toxicology by the American Board of Toxicology (DABT). He was the President of the North Carolina Society of Toxicology (NCSOT) in 1996. He is currently a Member of SOT (Past President of the Carcinogenesis Specialty Section), AACR, and Environmental Mutagen Society National & NC Chapters (GEMS Board of Directors 1992–1995; president since 2001) and is an Associate Editor for Toxicological Sciences. He has published approximately 120 manuscripts and book chapters on the mechanisms of toxicity. His current research interests include defining genetic factors influencing idiosyncratic drug toxicity.
Biography Updated on 26 November 2013